Dianthus Therapeutics @dianthustx
Unlocking the full potential of complement therapeutics through the power of selectivity. dianthustx.com Waltham, MA Joined December 2021-
Tweets22
-
Followers43
-
Following45
-
Likes9
Meet Indrajit! When he’s not volunteering at non-profit organizations in service of underprivileged children in third world countries, you can find him running, gardening or training to be a scuba diver. We’re honored to have you on our team, Indrajit! #OurTeam #GrowWithUs
Dianthus is pleased to share that the first healthy volunteers have been dosed in a Phase 1 clinical trial of our lead #ComplementTherapy, DNTH103, a next-generation selective inhibitor of the classical complement pathway. Learn more: prnewswire.com/news-releases/…
Our new Careers page is LIVE! Learn more about our people, values, benefits and how you can #GrowWithUs at Dianthus. Visit dianthustx.com/careers to find your next career. #BiotechJobs #NowHiring #BostonJobs #NYCJobs
Happy Thanksgiving from team Dianthus! We are especially thankful for our amazing employees, investors, and board for their work and support this year.
If you’re at the @Jefferies Healthcare Conference next week, keep an eye out for our very own Marino Garcia (CEO) and Ryan Savitz (CFO). Reach out if you’re interested in learning more about our fit-for-purpose development strategy in #ComplementTherapeutics.
Last month, we were thrilled to unveil the new Dianthus company #values to our full team and hold thoughtful discussions around building a company #culture where we can #CultivateTrust, #DigDeep, #GrowTogether & #ReachHigher.
Our team showed off their mad skills this week. #Halloween #Connection #OurTeam
We are thrilled to unveil our new office located in Times Square! Our dual HQs in NYC and Waltham, MA – combined with our hybrid-remote working model supporting teams across 10 states – allow us to recruit the best talent nationwide. Come #GrowWithUs – we’re #hiring!
#DefiningDianthus: Building on the legacy and meaning behind our company name, our values tell the story of how we create a workplace where everyone can thrive. Come #GrowWithUs. Visit dianthustx.com to find your next career.
Why "Dianthus"? Dianthus is a flower that resembles the elegant crystalline structure of the C1 complex targeted by our lead complement therapy candidate, DNTH103. Learn more about who we are here: dianthustx.com #biotech #RareDisease
Thank you to Glenda Thomas for taking the time to share your story with our team and for dedicating your time for the advocacy of patients with #MyastheniaGravis and #RareDiseases. To learn more about Glenda’s story, click here: youtu.be/UqmCIscX9n0
Last week, we were thrilled to gather our teams at our 2022 Fall Company Offsite! As Dianthus grows, we are intentionally building a team that is united by a shared commitment to our people and our mission - so we can create a workplace where everyone thrives. Come grow with us.
Are you an executive leader with a passion for shaping the future of #autoimmune disease therapies? We’re #hiring a Head of Research & Innovation to lead our discovery and pipeline strategies. Learn more here: bit.ly/3RmbxIB #BiotechJobs
Are you a senior legal strategist looking for the opportunity to make a lasting impact on a leading #biotech company? We are #hiring! Apply for our #GeneralCounsel position at: boards.greenhouse.io/dianthustherap… #biotechJobs
We are thrilled to welcome Scott Nogi as our Head of Operations! Scott joins Dianthus with 20+ years of experience in operations management & business development. Visit dianthustx.com to learn more about our #DrugDevelopment experts & next-gen #ComplementTherapeutics.
We are excited to expand our leadership team with the appointments of Ryan Savitz as CFO, Polly Hanff as Head of Quality, and Judson Taylor as Head of Technical Operations. Visit dianthustx.com for more. #ComplementTherapeutics #BiotechNews
@dianthustx launched Tuesday with $100 million in Series A financing led by 5AM Ventures, Avidity Partners and Fidelity Research and Management. #DianthusTherapeutics #AutoimmuneDiseases #BioSpace hubs.li/Q019nFzh0
@dianthustx blossoms with $100M series A round to target complement system bioworld.com/articles/51845… #biotech #pharma
In @BioCentury's latest Emerging Company Profile, @BioBonanos reports on @dianthustx, which has raised $121M for engineered complement mAbs. The company is backed by the family office of Lonnie Moulder, former CEO of Tesaro. Details: biocentury.com/article/643407
Dianthus Therapeutics is taking the wraps off a $100 million Series A as it explains its mission. endpts.com/5am-avidity-fi…
Amanda Rowe @rowe_amand8133
2 Followers 308 Followingyusuf kezimbira @YKezimbira
21 Followers 713 FollowingJonathan Lee @ColdCasanova1
38 Followers 286 FollowingShovel-Stocks @ShovelStocks
3K Followers 396 Following Investor | #Biotech #Semiconductors #Tech #Materials #QuantumComputing #FusionEnergy #Radiopharma #Microcap #SmallCapsharvard homeboy @harvard_homeboy
144 Followers 764 FollowingAce @Ace824169765225
167 Followers 762 FollowingDevesh Chaturvedi @DCFSROCK
112 Followers 1K Following LOAN AGAINST SECURITIES MUTUAL FUNDS AND SOVEREIGN GOLD BOND 9324605011 / 907600961Denville Partners @denvillepartner
397 Followers 2K Following #Executivesearch firm focused on supporting clients in Biotechnology, Pharmaceuticals, and industry related nonprofits.Jimmy Chien-ho Khaw @SieurWaliow
424 Followers 5K Following Fav FC / @ChelseaFC 🗣️ 中文/English/Français #FightForIndependence #StandWithHK #HKNationalism #StandWithUkraine #StandWithZelenskyy #SaveUkraine #SlavaUkrainiNasdaq Exchange @NasdaqExchange
762K Followers 8K Following At @Nasdaq, we power stronger economies, create more equitable opportunities, and contribute to a more sustainable world. #NasdaqListedCatalio Capital Manag.. @CatalioCapital
652 Followers 222 Following We invest in breakthrough biomedical technology companies founded by the world’s leading scientist-entrepreneursNo. Long. Talking. @NoLongTalking
157 Followers 2K FollowingAna Georgescu @GeorgescuVS
3 Followers 18 Followingrehan verjee @rvjee
172 Followers 1K FollowingAudax Clinical @audaxclinical
42 Followers 118 Following Providing Project Management and Clinical Operational support to early stage biotechs.Catherine 🏴☠�.. @DetailJunkie
2K Followers 5K Following She/Her. Biotech/pharma IR & public affairs. Patient advocate, clumsy runner & globe trotting nomad. Semper Doctrina.🏃♀️🎿🏊♀️ 🚲 ⚽️🤟🎵💉😷🐾📚🏳️🌈🏳️⚧️Sharon mowry @mowry_sharon
22 Followers 230 FollowingKristen Galfetti @kpgalfetti
41 Followers 72 Following Corporate communications / investor relations professional passionate about providing clear, consistent messages effectively to a broad audience.George Petrocheilos @georgecpetro
1K Followers 2K Following Co-Founder & Managing Partner of @CatalioCapital, a multi-strategy investment firm focusing on disruptive biomedical tech companiesBioanalytical Scienti.. @BA_Sciences
100 Followers 122 Following Bioanalytical Sciences focus on PK, ADA, NAb, biomarkers.Cindy Sutton @CindySu85664739
606 Followers 2K Following Happiness is what dreams are made of respectable intellectual be the best you can be miracles happenGary GAMBLE @GaryGamble88
33 Followers 115 Following Account Executive at Medidata Solutions, a Dassault Systèmes company #raredisease #clinicaltrials #lifesciences #biopharma #artificialintelligenceGreg Kelley @GregKelley
51 Followers 388 FollowingAustin Caudle, MSc, M.. @caudleag
116 Followers 620 Following Quality & reg intel data analytics, scientist, and people connector. President, PDA Southeast Chapter Board of Directors.💊🧬Lauren Valentine Elle.. @Valentine_Eller
129 Followers 1K Following Devoted Mom. Biotech strategist. Patient-centric, people-focused. Drive healthcare advances, access, & outcomes - to enhance lives. Opinions my own.Schwab 5AM @Schwab5AM
4K Followers 2K Following Founder & Managing Partner of 5AM Ventures. Med school drop-out and former biotech I-banker with a passion for entrepreneurship. Cincy, SF & Davidson fan...peoplepath.io @peoplepath_io
73 Followers 157 Following A REVOLUTION IN RECRUITING We are a client-focused recruiting firm, optimized to deliver top talent quickly.5AM Ventures @5amVentures
2K Followers 70 Following Dedicated to taking a diversified, hands-on investment approach to creating value in early-stage life science companiesmatt krebs @krebs_matt
5K Followers 5K Following Head of @BioCentury 's global new business sales operations. Post news, analysis and events on the biopharma industry. Mostly from https://t.co/BIv0E1aVuBPaula Soteropoulos @psoteropoulos
311 Followers 152 Following Chairman, Ensoma; Board Director uniQure, Rallybio, Dianthus, Kyowa Kirin NA; Venture Partner 5AM VenturesAlex @acesobiologics
157 Followers 473 FollowingAlex Philippidis @AlexWestchester
6K Followers 5K Following Senior Business Editor, Genetic Engineering & Biotechnology News, GEN Edge, and Mary Ann Liebert Inc., New Rochelle, NY. https://t.co/b3rRmjLrzsDavid Grainger @sciencescanner
14K Followers 797 Following Biotech entrepreneur & Partner @Medicxi Advocate of virtual, asset-centric R&D. All opinions my ownRyan @Ryan12821019
17 Followers 111 FollowingMarinonyc @MarinoNYC2015
26 Followers 134 FollowingTimmerman Report @timmermanreport
7K Followers 4 Following Timmerman Report is an independent biotech publication. Subscribe today! https://t.co/0HEk9RZHMV…Jeff Cranmer @jeff_cranmer
3K Followers 1K Following Executive Editor, @BioCentury. Jersey boy happily ensconced in Cali. Dad. Failed poet. Devoted Iggles fan. Cats. @Princeton, @SAISHopkins alum. Opinions? Mine.5AM Ventures @5amVentures
2K Followers 70 Following Dedicated to taking a diversified, hands-on investment approach to creating value in early-stage life science companiesAnissa Gardizy @anissagardizy8
5K Followers 3K Following reporter at @theinformation covering AWS and the cloud. previously @bostonglobe tech reporter. send tips to [email protected] / DM for Signal, etcRyan Cross the Scienc.. @RLCscienceboss
4K Followers 844 Following Senior Science Correspondent for @Endpts covering biotech, drug discovery, gene editing, RNA, and more. Formerly at Boston Globe and C&EN. Threads: ryancrossLuke Timmerman @ldtimmerman
35K Followers 231 Following Biotech Journalist. Founder @TimmermanReport. Mountaineer. Volunteer. @LS_Cares @DamonRunyonMatthew Herper @matthewherper
111K Followers 3K Following Writing and events at STAT. This is biology's century; Every data point has a face. ‘21 Polk Award. Mastodon: @[email protected]Adam Feuerstein ✡�.. @adamfeuerstein
114K Followers 750 Following Reporter @statnews. The Harry Kane of biotech. Dog ❤️er. Polk Award winner. #COYS. Said one analyst: The likes of Adam Feuerstein attack viciously.Megan Molteni @MeganMolteni
8K Followers 2K Following science writer @statnews | formerly @WIRED | she/her | genetic privacy & Crispr tips to [email protected] | DM for signalFrank Vinluan @frankvinluan
2K Followers 781 Following Business journalist based in #RTP, covering pharma and biotech (almost) everywhere. 71% free throw shooter. Genesis: Album 9, track 11.Alex Philippidis @AlexWestchester
6K Followers 5K Following Senior Business Editor, Genetic Engineering & Biotechnology News, GEN Edge, and Mary Ann Liebert Inc., New Rochelle, NY. https://t.co/b3rRmjLrzsKyle LaHucik @ky_lahucik
3K Followers 2K Following covering the VC $, people, deals + biotechs behind new meds @Endpts | [email protected] | askin Qs, joggin 26.2 | 🗞 📷 🌎 | XC + Track coach | 🏳️🌈Amber Tong @AmberTongPW
3K Followers 872 Following senior editor & one-person HK bureau @endpts covering global biotech/pharma | news and tips → [email protected]Jason Mast @Jasonmmast
4K Followers 3K Following Writing about science, medicine & business for @statnews Email me: [email protected]Max Gelman @MaxGelman
2K Followers 495 Following Reporting on pharma and biotech, @endpts. Baseball fan, Northwestern alum. Email: [email protected]John Carroll @JohnCendpts
70K Followers 94 Following Working journalist for 46 years, invented FierceBiotech, founded Endpoints News now majority-@FT owned. 201,000 subscribers. These are personal opinions.Rowan Walrath @BosBizRowan
4K Followers 686 Following Covering life sciences at @BosBizJournal. More often found at @rowanwalrath. Fully vaxed, for planning purposes. she/her. [email protected]Cormac Sheridan @Cormac_Sheridan
2K Followers 5K Following Freelance science journalist. I write about what works in biotech - & what doesn't. Write for @NatureBiotech & one half of Smith & Sheridan on Biotech podcastStephen Hansen 🇺�.. @StephenPHansen
636 Followers 561 Following Husband. Father of 2 exhausting boys. Director of Biopharma Intelligence @BioCentury. Lives → U.K., roots in Minnesota. Opinions my own. Landscape photography⬇⬇WIRED @WIRED
10.0M Followers 452 Following Where tomorrow is realized || Sign up for our newsletters: https://t.co/webmuFK9lNThe Pharma Letter @ThePharmaLetter
24K Followers 2K Following Breaking news and analysis for the global pharmaceutical and biotechnology industriesSTAT @statnews
165K Followers 5K Following Reporting from the frontiers of health & medicine. Sign up for any of our 10 free newsletters here: https://t.co/CBx3GZBv31Science Magazine @ScienceMagazine
4.0M Followers 483 Following The world's leading outlet for cutting-edge research in all areas of science. Follow @NewsfromScience for stories from our news team.Scientific American @sciam
4.4M Followers 834 Following Awesome discoveries. Expert insights. Science that shapes the world.Nature Biotechnology @NatureBiotech
302K Followers 2K Following Publishing the very best of biotech science and business. Part of @SpringerNature and @NaturePortfolio. On Facebook (natbiotechnol) & IG (nature.biotechnology)FirstWord Pharma @fwpharma
55K Followers 625 Following The latest global #pharma news, insights, analysis, and views providing you with an information edge. FirstWord Pharma. Where people who know first, go first.FiercePharma @FiercePharma
98K Followers 485 Following Pharma’s go-to destination for news & trends shaping approved drugs. Delivering news, revealing insights straight to your inbox.FierceBiotech @FierceBiotech
101K Followers 649 Following The dominant B2B news brand for biotech. Delivering news, revealing insights straight to your inbox.Endpoints News @endpts
29K Followers 68 Following The biopharma world is here. Get the industry’s most comprehensive daily news reports at https://t.co/qpcDlbaOSxCrunchbase News @crunchbasenews
29K Followers 4K Following Data-driven reporting on private markets, startups, founders, and investors. Send tips to: [email protected]C&EN (Chemical & Engi.. @cenmag
121K Followers 962 Following Sharing the world of #chemistry: News🗞 Research⚗️ Infographics #PeriodicGraphics ℹ Pictures #CENChemPics 📷 Comics #SketchChemistry 🗯 #FluorescenceFriday ❇️Business Insider @BusinessInsider
4.0M Followers 411 Following What you want to know about business. Follow us on Facebook, Instagram, and YouTube. Visit our homepage for the day's top stories.Boston Business Journ.. @BosBizJournal
73K Followers 26K Following Breaking news and other stories from the Boston Business Journal. Follow @BosBizEvents for updates from the BBJ's events and marketing team.BioPharma Dive @BioPharmaDive
13K Followers 320 Following We provide in-depth insight into the most significant news and trends shaping biotech and pharma. Sign up here: https://t.co/sTgs1kxwYEThe Wall Street Journ.. @WSJ
20.6M Followers 1K Following Sign up for our newsletters and alerts: https://t.co/QevH0DLisA | Got a tip? https://t.co/iXIigdOLPr | For WSJ customer support: https://t.co/DZgH9n4vAINew York Business Jou.. @NYBizJournal
3K Followers 444 Following The New York region's source for local business news & events. Part of the American City Business Journals network. Subscribe today! https://t.co/X6J74LBp9kMedCity News @medcitynews
33K Followers 7K Following Tracking what's next in medical innovation from hospitals, payers, medtech, pharma, digital & beyond. A @breakingmedia site.Bloomberg @business
9.5M Followers 80 Following The first word in business news. Newsletters: https://t.co/nWaCxHSKuU Podcasts: https://t.co/096e9xMbPzThe Boston Globe @BostonGlobe
797K Followers 972 Following New England's leading source for breaking news and analysis.BioCentury @BioCentury
16K Followers 2K Following The leading voice for decision-makers throughout the global biopharma ecosystem. Follow us on LinkedIn for exclusive insights & analysis: https://t.co/V33Z1gfUfZBioWorld @BioWorld
39K Followers 9K Following Biopharma’s trusted news source. Lynn Yoffee, Jennifer Boggs, Karen Carey, Anette Breindl, Lee Landenberger, Randy Osborne, Mari Serebrov, Caroline RichardsThe New York Times @nytimes
55.2M Followers 879 Following News tips? Share them here: https://t.co/ghL9OoYKMM@dianthustx, Enavate Sciences and CytoTronics were all launched with this recent wave of investor funding. For that and more, continue reading. #DianthusTherapeutics #EnavateSciences #CytoTronics #BioSpace hubs.li/Q019wgy50
@dianthustx launched Tuesday with $100 million in Series A financing led by 5AM Ventures, Avidity Partners and Fidelity Research and Management. #DianthusTherapeutics #AutoimmuneDiseases #BioSpace hubs.li/Q019nFzh0
@dianthustx blossoms with $100M series A round to target complement system bioworld.com/articles/51845… #biotech #pharma
@dianthustx blossoms with $100M series A round to target complement system bioworld.com/articles/51845… #biotech #pharma
Congrats to @dianthustx, a #biotech company dedicated to advancing the next generation of antibody complement therapeutics, on launching with a $100M Series A funding round! vnrk.co/3KHok4f
In @BioCentury's latest Emerging Company Profile, @BioBonanos reports on @dianthustx, which has raised $121M for engineered complement mAbs. The company is backed by the family office of Lonnie Moulder, former CEO of Tesaro. Details: biocentury.com/article/643407
Dianthus Therapeutics is taking the wraps off a $100 million Series A as it explains its mission. endpts.com/5am-avidity-fi…
With $121M in total backing from VCs, @dianthustx will advance its lead complement mAb into the clinic this year, setting up a potential challenger to a newly approved @sanofi product: a @BioCentury Emerging Company Profile buff.ly/3OQQnkR
A new biotech startup by the name of Dianthus Therapeutics is launching with the goal of making drugs for autoimmune disorders a little less burdensome. bizjournals.com/boston/news/20…